Back
EHRA Premium Access

Efficacy of non-vitamin k antagonist oral anticoagulants for perioperative complication in patients with atrial fibrillation undergoing catheter ablation.

Session: Moderated Poster session 5 - Treatment strategies and ablation outcome
Topic: Catheter ablation (Atrial Fibrillation)
Speaker: Doctor T. Iseda (Wakayama, JP)
Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

Add to my library

Like

About the speaker

Doctor Takahiro Iseda

Japan Red Cross Society Wakayama Medical Center, Wakayama (Japan)
0 follower

7 more presentations in this session

Predictors of serious complications during and immediately after catheter ablation of atrial fibrillation in 8302 procedures: J-CARAF Study

Speaker: Professor Y. Murakawa (Kawasaki, JP)

Access
Abstract
Slides
Like
Thumbnail

Is the transesophageal echocardiography mandatory in patients undergoing atrial fibrillation ablation with uninterrupted novel anticoagulants?

Speaker: Doctor A. Shapieva (Moscow, RU)

Access
Abstract
Slides
Like
Thumbnail

The incidence of complications in the setting of second-generation cryoballoon ablation of atrial fibrillation: a comparison between vitamin K antagonists and novel oral anticoagulants

Access
Like
Thumbnail

Long-term outcomes of supraventricular tachycardia ablation in congenital heart disease: single centre uk experience

Speaker: Doctor V. Sawhney (London, GB)

Access
Abstract
Like
Thumbnail

Long-term outcomes after catheter ablation of ventricular tachycardia in patients with structural heart disease: a Multicentre UK Study

Speaker: Doctor A. Breitenstein (Zurich, CH)

Access
Abstract
Like
Thumbnail

Access the full session

Moderated Poster session 5 - Treatment strategies and ablation outcome

Speakers: Doctor T. Iseda, Professor Y. Murakawa, Doctor A. Shapieva, Doctor V. Sawhney, Doctor A. Breitenstein
Access
Like
Thumbnail

About the event

Image

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources